Catheter Ablation of Arrhythmias to Improve CRT Response (ABLATE-CRT)

K

Kansas City Heart Rhythm Institute

Status and phase

Terminated
Phase 4

Conditions

Arrhythmia, Cardiac

Treatments

Drug: Anti-Arrhythmics
Procedure: Catheter Ablation

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03035227
STUDY00003861

Details and patient eligibility

About

The purpose of this study is to test if catheter ablation is better than medication therapy at treating arrhythmias originating from the upper and/or lower chambers of the heart in order to allow the heart to beat properly.

Enrollment

2 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Heart failure patients with CRT-D or CRT-P greater than 3 months
  • Bi-ventricular pacing less than 94% of the time
  • 3 months after CRT-D or CRT-P implantation an EF improvement less than 5%

Presence of one of the following arrhythmias and eligible for catheter ablation:

  • Atrial fibrillation
  • Atrial flutter
  • Supraventricular tachycardia
  • Premature ventricular contraction burden greater than 30% in a 24-hour period
  • Ventricular tachycardia

Exclusion criteria

  • Estimated survival less than one year
  • Patient unable to make scheduled follow up visits at treating center
  • Participating in another investigational study

Trial design

2 participants in 2 patient groups

Catheter Ablation
Active Comparator group
Description:
Catheter ablation procedure of atrial and/or ventricular arrhythmias.
Treatment:
Procedure: Catheter Ablation
Medical Therapy
Active Comparator group
Description:
Medical management using antiarrhythmic drugs per standard of care of treating physician.
Treatment:
Drug: Anti-Arrhythmics

Trial documents
1

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems